Cargando…
Discovery of a Novel Inhibitor Structure of Mycobacterium tuberculosis Isocitrate Lyase
Tuberculosis remains a global threat to public health, and dormant Mycobacterium tuberculosis leads to long-term medication that is harmful to the human body. M. tuberculosis isocitrate lyase (MtICL), which is absent in host cells, is a key rate-limiting enzyme of the glyoxylic acid cycle and is ess...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026967/ https://www.ncbi.nlm.nih.gov/pubmed/35458645 http://dx.doi.org/10.3390/molecules27082447 |